HIGHLIGHTS
- who: Bo Zhou and Jianqing She from the Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi`an Jiaotong University, Xi`an, China, Cardiology have published the Article: Case Report: Acute Myocarditis Due to PD-L1 Inhibitor Durvalumab Monotherapy in a Patient With Lung Squamous Cell Carcinoma, in the Journal: (JOURNAL)
- what: The authors report a rare case of a 67-year-old male with lung squamous cell carcinoma complicated with empyema who experienced myocarditis after only PD-L1 inhibitor durvalumab monotherapy.
SUMMARY
Immune checkpoint inhibitors (ICIs) has brought . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.